These results are in accord with the previous reports that human recombinant TMSB10 promoted VEGF-C expression in lung cancer cells [60], and that recombinant VEGF treatment elevated the expression level of human TMSB10 in endothelial cells [61]. This evidence concerns the gene TMSB10 and lung carcinoma.